{
    "study_accession": "SDY939",
    "actual_completion_date": null,
    "actual_enrollment": 4,
    "actual_start_date": "2014-01-01",
    "age_unit": "Years",
    "brief_description": "CD4+ T cells are central mediators of autoimmune pathology; however, defining their key effector functions in specific autoimmune diseases remains challenging. CD4+ T cells with high PD-1 expression are expanded in rheumatoid arthritis patients.",
    "brief_title": "Pathologically expanded peripheral B cell-helper T cells in Rheumatoid Arthritis",
    "clinical_trial": "N",
    "condition_studied": "Rheumatoid Arthritis",
    "dcl_id": 1,
    "description": "CD4+ T cells are central mediators of autoimmune pathology; however,",
    "doi": "10.21430/M3OLBPJIB1",
    "endpoints": "CDAI, mass cytometry (CyToF) , flow cytometry, RNA Sequencing, ELISA, Intracellular cytokine staining, intracellular transcription factor staining, RT-PCR, in vitro cell stimulation assays",
    "gender_included": "Not Specified",
    "hypothesis": "Subpopulations of CD4+ T cells associated with rheumatoid arthritis pathology can be found with multidimensional cytometry and gene expression analysis.",
    "initial_data_release_date": "2017-01-31",
    "initial_data_release_version": "DR20",
    "intervention_agent": null,
    "latest_data_release_date": "2017-04-21",
    "latest_data_release_version": "DR21",
    "maximum_age": "  64.00",
    "minimum_age": "  37.00",
    "objectives": "Identify biomarkers of subpopulations of CD4+ T cells associated with rheumatoid arthritis pathology",
    "official_title": "Pathologically expanded peripheral B cell-helper T cells in Rheumatoid Arthritis",
    "sponsoring_organization": "William Docken Inflammatory Autoimmune Disease Fund",
    "target_enrollment": null,
    "workspace_id": 5881,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM3463",
            "description": "rheumatoid factor+ or anti-citrullinated peptide antibody+",
            "name": "seropositive rheumatoid arthritis"
        },
        {
            "arm_accession": "ARM3464",
            "description": "rheumatoid factor- or anti-citrullinated peptide antibody-",
            "name": "Spondyloarthropathy"
        },
        {
            "arm_accession": "ARM3465",
            "description": "rheumatoid factor- or anti-citrullinated peptide antibody-",
            "name": "seronegative rheumatoid arthritis"
        },
        {
            "arm_accession": "ARM3466",
            "description": "rheumatoid factor- or anti-citrullinated peptide antibody-",
            "name": "juvenile idiopathic arthritis"
        }
    ],
    "personnel": [
        {
            "first_name": "Michael",
            "last_name": "Brenner",
            "organization": "Division of Rheumatology, Immunology, and Allergy, Brigham and Womens Hospital and Harvard Medical School",
            "role_in_study": "Principal Investigator",
            "site_name": "Brigham and Women's Hospital"
        }
    ],
    "pubmed": [
        {
            "title": "Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.",
            "journal": "Nature.",
            "month": "Feb",
            "year": "2017",
            "doi": "10.1038/nature20810.",
            "pubmed_id": "28150777"
        }
    ],
    "program": [
        {
            "program_name": "PROSET-HD Profiling of Cell Subsets in Human Disease",
            "contract_name": "PROSET-HD Profiling of Cell Subsets in Human Disease"
        }
    ],
    "assay": [
        {
            "measurement_technique": "RNA sequencing",
            "number_of_expsamples": 64
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Not Specified",
                "count": 4
            }
        ],
        "gender": [
            {
                "Female": 3
            },
            {
                "Male": 1
            }
        ]
    }
}
